THYMOCYTE IMMUNE GLOBULIN NOS for Bone marrow conditioning regimen: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 742 adverse event reports in the FDA FAERS database where THYMOCYTE IMMUNE GLOBULIN NOS was used for Bone marrow conditioning regimen.
Most Reported Side Effects for THYMOCYTE IMMUNE GLOBULIN NOS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 749 | 13.5% | 242 | 300 |
| Drug ineffective | 692 | 12.5% | 226 | 245 |
| Cytomegalovirus infection | 404 | 7.3% | 127 | 126 |
| Product use in unapproved indication | 396 | 7.1% | 122 | 86 |
| Transplant rejection | 340 | 6.1% | 22 | 68 |
| Post transplant lymphoproliferative disorder | 319 | 5.7% | 182 | 103 |
| Epstein-barr virus infection | 255 | 4.6% | 126 | 58 |
| Pneumonia | 254 | 4.6% | 104 | 104 |
| Multiple organ dysfunction syndrome | 250 | 4.5% | 227 | 119 |
| Coma | 247 | 4.4% | 19 | 231 |
| Pneumonia aspiration | 239 | 4.3% | 0 | 220 |
| Somnolence | 235 | 4.2% | 6 | 223 |
| Cytomegalovirus viraemia | 228 | 4.1% | 33 | 73 |
| Gastrooesophageal reflux disease | 227 | 4.1% | 0 | 216 |
| Pyrexia | 224 | 4.0% | 62 | 137 |
Other Indications for THYMOCYTE IMMUNE GLOBULIN NOS
Immunosuppressant drug therapy (1,431)
Prophylaxis against graft versus host disease (614)
Product used for unknown indication (494)
Immunosuppression (451)
Prophylaxis against transplant rejection (308)
Allogenic stem cell transplantation (269)
Aplastic anaemia (249)
Renal transplant (247)
Stem cell transplant (233)
Transplant rejection (173)
Other Drugs Used for Bone marrow conditioning regimen
FLUDARABINE (6,080)
BUSULFAN (4,669)
CYCLOPHOSPHAMIDE (4,485)
MELPHALAN (2,368)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884)
THIOTEPA (1,551)
ALEMTUZUMAB (1,122)
ETOPOSIDE (936)
CYTARABINE (833)
TREOSULFAN (695)